Home business company profiles reviews & industry history since 1999

4Life mentioned in Fiji Times


The key to long life is our immune system being in excellent shape and functioning optimally. In a recent research study by 4Life Research, USA was noted as a manufacturer of an important transfer factor.

According to Australian physician in Biomedicine Dr Valentina Szabo, transfer factors belong to the family of cytokines, which are tiny peptide molecules that exist in the human body making the immune system quicker to respond to diseases.

"If our immune system would be strong we would not become sick," she said.

Transfer factor is a content of a capsule and available in a liquid form which can be injected, and is produced by the company 4Life Research, USA.

"TFs can be used in combination with conventional medications and in combination with naturopathic preparations in a holistic approach in treatment of immune disorders.

Please see the link below for the full article.

More 4Life Research news

4Life Opens New Manufacturing Facility

SALT LAKE CITY, UT--December 01, 2015 - Today, 4Life General Managers from around the world gathered for a ribbon-cutting at the new 4Life manufacturing facility in Vineyard...

4Life Launches 4LifeTransform

SALT LAKE CITY, UT-- Apr 16, 2015 - Today, in front of more than 7,000 people from 70 countries, 4Life launched the new 4LifeTransform product line, featuring the much anticipated...

4Life Research Partners with Auburn University

SALT LAKE CITY, UT--Aug 15, 2014 - Today, Auburn University announced a $100,000 gift from 4Life Research®. The Molecular and Applied Sciences Laboratory in the School of...

4Life Receives Philanthropy Award

SALT LAKE CITY, UTAH--The Nutrition Business Journal (NBJ) named 4Life as the recipient of its prestigious 2013 Philanthropy Award. The nutrition industry's most noteworthy...

4Life Research Names New CEO

SALT LAKE CITY, UT -- 4Life President Steve Tew was named the company's Chief Executive Officer (CEO). Former CEO, company Founder David Lisonbee, will continue in his position as...